MiNK Therapeutics (INKT) Q4 2025 Earnings

14NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.06
-0.87
-0.68
-0.49

Details

Expected EPS
-0.855
Actual EPS
-0.65
Surprise EPS
0.2
Surprise Percent
+23.98%

Description

MiNK Therapeutics (INKT) has reported earnings of -0.65 per share for Q4 2025.

0 Comments

Share your thoughts